Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07429318
Eligibility Criteria:
Inclusion Criteria:
* (1) Pathologically diagnosed as gastric adenocarcinoma or esophageal-gastric junction adenocarcinoma, and has not received any anti-tumor treatment before (such as surgery, radiotherapy, chemotherapy, targeted therapy, immunotherapy, etc.)
* (2) cT3-4N+M0 (according to AJCC version 8 stage) confirmed as resectable by CT or MRI.
* (3) Patients who underwent adjuvant therapy before surgery.
* (4) After neoadjuvant therapy , radical resection was performed at the Cancer Hospital of the Chinese Academy of Medical Sciences.
* (5) Patients who have complete clinical, pathological and imaging data.
Exclusion Criteria:
* (1) It is known that peritoneal metastasis or peritoneal irrigation solution cytology is positive (CY1P0) or there is distant metastasis (according to the 8th edition of AJCC).
* (2) There are unresectable factors, including irresectable tumor causes or surgical contraindications that are irresectable or refuse surgery.
* (3) Those who have suffered from other malignant tumors within 5 years or at the same time, except for cured skin basal cell carcinoma and cervical cancer in situ and breast cancer in situ.
* (4) Those who have had radiotherapy, interventional treatment and other local therapists before surgery.
* (5) Patients whose key diagnosis and treatment information records were missing.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07429318
Study Brief:
Protocol Section:
NCT07429318